Can advanced non-small-cell lung cancer be treated with weekly instead of 3-weekly docetaxel?

被引：3
作者：
Scagliotti, G. V. [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, S Luigi Hosp Reg Gozole 10, I-10043 Turin, Italy
[2] S Luigi Hosp, Thorac Oncol Unit, Turin, Italy
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 06期
关键词：
docetaxel; non-small-cell lung cancer; schedule; survival; toxicity;
D O I：
10.1038/ncponc0510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：294 / 295
页数：2
相关论文
共 6 条
[1]   Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer:: a Spanish Lung Cancer Group trial [J].
Camps, C ;
Massuti, B ;
Jiménez, A ;
Maestu, I ;
Gómez, RG ;
Isla, D ;
González, JL ;
Almenar, D ;
Blasco, A ;
Rosell, R ;
Carrato, A ;
Viñolas, N ;
Batista, N ;
Girón, CG ;
Galán, A ;
López, M ;
Blanco, R ;
Provencio, M ;
Diz, P ;
Felip, E .
ANNALS OF ONCOLOGY, 2006, 17 (03) :467-472
[2]   A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer.: The DISTAL 01 study [J].
Gridelli, C ;
Gallo, C ;
Di Maio, M ;
Barletta, E ;
Illiano, A ;
Maione, P ;
Salvagni, S ;
Piantedosi, FV ;
Palazzolo, G ;
Caffo, O ;
Ceribelli, A ;
Falcone, A ;
Mazzanti, P ;
Brancaccio, L ;
Capuano, MA ;
Isa, L ;
Barbera, S ;
Perrone, F .
BRITISH JOURNAL OF CANCER, 2004, 91 (12) :1996-2004
[3]   Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].
Hanna, N ;
Shepherd, FA ;
Fossella, FV ;
Pereira, JR ;
De Marinis, F ;
von Pawel, J ;
Gatzemeier, U ;
Tsao, TCY ;
Pless, M ;
Muller, T ;
Lim, HL ;
Desch, C ;
Szondy, K ;
Gervais, R ;
Shaharyar ;
Manegold, C ;
Paul, S ;
Paoletti, P ;
Einhorn, L ;
Bunn, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597
[4]   Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel [J].
Schuette, W ;
Nagel, S ;
Blankenburg, T ;
Lautenschlaeger, C ;
Hans, K ;
Schmidt, EW ;
Dittrich, I ;
Schweisfurth, H ;
von Weikersthal, LF ;
Raghavachar, A ;
Reissig, A ;
Serke, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8389-8395
[5]   Erlotinib in previously treated non-small-cell lung cancer [J].
Shepherd, FA ;
Pereira, JR ;
Ciuleanu, T ;
Tan, EH ;
Hirsh, V ;
Thongprasert, S ;
Campos, D ;
Maoleekoonpiroj, S ;
Smylie, M ;
Martins, R ;
van Kooten, M ;
Dediu, M ;
Findlay, B ;
Tu, DS ;
Johnston, D ;
Bezjak, A ;
Clark, G ;
Santabárbara, P ;
Seymour, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132
[6]   Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy [J].
Shepherd, FA ;
Dancey, J ;
Ramlau, R ;
Mattson, K ;
Gralla, R ;
O'Rourke, M ;
Levitan, N ;
Gressot, L ;
Vincent, M ;
Burkes, R ;
Coughlin, S ;
Kim, Y ;
Berille, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) :2095-2103
1